These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 2877604)

  • 1. Pathogenicity and immunogenicity of piliated and nonpiliated phases of Moraxella bovis in calves.
    Jayappa HG; Lehr C
    Am J Vet Res; 1986 Oct; 47(10):2217-21. PubMed ID: 2877604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infectious bovine keratoconjunctivitis: enhancement of Moraxella bovis pili immunogenicity with diphtheria-tetanus toxoids and pertussis vaccine.
    Pugh GW; Kopecky KE; McDonald TJ
    Am J Vet Res; 1984 Apr; 45(4):661-5. PubMed ID: 6145379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serologic and protective characterization of Moraxella bovis pili.
    Lehr C; Jayappa HG; Goodnow RA
    Cornell Vet; 1985 Oct; 75(4):484-92. PubMed ID: 2865080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterisation and quantitation of pilus antigens of Moraxella bovis by ELISA.
    Lepper AW; Hermans LR
    Aust Vet J; 1986 Dec; 63(12):401-5. PubMed ID: 2879528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of naturally occurring infectious bovine keratoconjunctivitis with a recombinant Moraxella bovis pilin-Moraxella bovis cytotoxin-ISCOM matrix adjuvanted vaccine.
    Angelos JA; Bonifacio RG; Ball LM; Hess JF
    Vet Microbiol; 2007 Dec; 125(3-4):274-83. PubMed ID: 17656049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized controlled field trial to assess efficacy of a Moraxella bovis pilin-cytotoxin-Moraxella bovoculi cytotoxin subunit vaccine to prevent naturally occurring infectious bovine keratoconjunctivitis.
    Angelos JA; Gohary KG; Ball LM; Hess JF
    Am J Vet Res; 2012 Oct; 73(10):1670-5. PubMed ID: 23013196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccination against infectious bovine keratoconjunctivitis: protective efficacy and antibody response induced by pili of homologous and heterologous strains of Moraxella bovis.
    Lepper AW
    Aust Vet J; 1988 Oct; 65(10):310-6. PubMed ID: 2904257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimentally induced infections bovine keratoconjunctivitis: effectiveness of a pilus vaccine against exposure to homologous strains of Moraxella bovis.
    Pugh GW; Hughes DE; Booth GD
    Am J Vet Res; 1977 Oct; 38(10):1519-22. PubMed ID: 931134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental infectious bovine keratoconjunctivitis: efficacy of a vaccine prepared from nonhemolytic strains of Moraxella bovis.
    Pugh GW; McDonald TJ; Kopecky KE
    Am J Vet Res; 1982 Jun; 43(6):1081-4. PubMed ID: 7103179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infectious bovine keratoconjunctivitis: subconjunctival administration of a Moraxella bovis pilus preparation enhances immunogenicity.
    Pugh GW; Kopecky KE; McDonald TJ
    Am J Vet Res; 1985 Apr; 46(4):811-5. PubMed ID: 2861768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infectious bovine keratoconjunctivitis: effects of vaccination on Moraxella bovis carrier state in cattle.
    Pugh GW; McDonald TJ; Kopecky KE
    Am J Vet Res; 1980 Feb; 41(2):264-6. PubMed ID: 7369598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The protective efficacy of pili from different strains of Moraxella bovis within the same serogroup against infectious bovine keratoconjunctivitis.
    Lepper AW; Moore LJ; Atwell JL; Tennent JM
    Vet Microbiol; 1992 Sep; 32(2):177-87. PubMed ID: 1359693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Whole-bacterial cell enzyme-linked immunosorbent assay for cell-bound Moraxella bovis pili.
    Prieto CI; Rodriguez ME; Bosch A; Chirdo FG; Yantorno OM
    Vet Microbiol; 2003 Feb; 91(2-3):157-68. PubMed ID: 12458165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serologic cross-reactivity of Australian Moraxella bovis to vaccinal bacterin strains as determined by competitive ELISA.
    McConnel CS; Shum L; Gleeson BL; House JK
    Aust Vet J; 2008 Apr; 86(4):124-9. PubMed ID: 18363984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccine against infectious bovine keratoconjunctivitis: a new approach to optimize the production of highly piliated Moraxella bovis cells.
    Prieto CI; Bosch A; Zielinski G; Cúneo J; Yantorno OM
    Vaccine; 2008 Dec; 26(51):6542-9. PubMed ID: 18852003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of naturally occurring infectious bovine keratoconjunctivitis with a recombinant Moraxella bovis cytotoxin-ISCOM matrix adjuvanted vaccine.
    Angelos JA; Hess JF; George LW
    Vaccine; 2004 Dec; 23(4):537-45. PubMed ID: 15530703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of two commercial infectious bovine keratoconjunctivitis vaccines.
    Smith PC; Blankenship T; Hoover TR; Powe T; Wright JC
    Am J Vet Res; 1990 Jul; 51(7):1147-50. PubMed ID: 2389894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation of Moraxella bovis ribosomes and their subsequent use in a vaccine against infectious bovine keratoconjunctivitis.
    Pugh GW; Phillips M; McDonald TJ; Kopecky KE
    Am J Vet Res; 1981 Mar; 42(3):516-20. PubMed ID: 7271018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enzyme-linked immunosorbent assay for measurement of anti-Moraxella bovis antibodies.
    Bishop B; Schurig GG; Troutt HF
    Am J Vet Res; 1982 Aug; 43(8):1443-5. PubMed ID: 7049023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The protective efficacy of cloned Moraxella bovis pili in monovalent and multivalent vaccine formulations against experimentally induced infectious bovine keratoconjunctivitis (IBK).
    Lepper AW; Atwell JL; Lehrbach PR; Schwartzkoff CL; Egerton JR; Tennent JM
    Vet Microbiol; 1995 Jul; 45(2-3):129-38. PubMed ID: 7571364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.